FF
DGX icon

Farrow Financial’s Quest Diagnostics DGX Stock Holding History

Farrow Financial’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.84M Buy
13,420
+109
+0.8% +$21.4K 1.52% 24
2026
Q1 		$2.61M Sell
13,311
-358
-3% -$69.6K 1.48% 26
2025
Q4 		$2.37M Sell
13,669
-287
-2% -$52.3K 1.36% 30
2025
Q3 		$2.66M Sell
13,956
-33
-0.2% -$5.86K 1.54% 26
2025
Q2 		$2.51M Sell
13,989
-202
-1% -$35.1K 1.52% 26
2025
Q1 		$2.4M Sell
14,191
-531
-4% -$87.2K 1.61% 24
2024
Q4 		$2.22M Sell
14,722
-64
-0.4% -$9.95K 1.44% 28
2024
Q3 		$2.3M Sell
14,786
-489
-3% -$73K 1.45% 26
2024
Q2 		$2.09M Buy
15,275
+141
+0.9% +$19.3K 1.43% 27
2024
Q1 		$2.01M Buy
15,134
+1,591
+12% +$206K 1.41% 31
2023
Q4 		$1.87M Buy
+13,543
New +$1.78M 1.41% 32

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Farrow Financial's DGX Position: Q2 2026 in Review

Farrow Financial increased its Quest Diagnostics (DGX) stake by 0.82% in Q2 2026, buying an estimated $21.4K and bringing the position to 13,420 shares worth $2.84M. The position accounts for 1.52% of the portfolio, ranked #24.

Farrow Financial first reported a position in DGX in Q4 2023 and has held it in 11 quarters since. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Farrow Financial held 13,420 shares of Quest Diagnostics worth $2.84M as of Q2 2026.
  • Farrow Financial bought 109 Quest Diagnostics shares in Q2 2026, an estimated $21.4K.
  • Quest Diagnostics made up 1.52% of Farrow Financial's portfolio in Q2 2026, its #24 holding.
  • Farrow Financial first reported a position in Quest Diagnostics in Q4 2023 and has held it in 11 quarters since.
  • 1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Farrow Financial's 13F filing for Q2 2026, filed 4 Aug 2026.